Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Triamcinolone is a glucocorticoid used to treat certain skin diseases, allergies, and rheumatic disorders among others. It is also used to prevent worsening of asthma and chronic obstructive pulmonary disease (COPD). It can be taken in various ways including by mouth, injection into a muscle, and inhalation.
The analysis highlights Community, Culture, Applications and Standards as prominent areas in the source structure around Triamcinolone.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Triamcinolone shows recurring relationship patterns in the source. For example, Triamcinolone → ACE, Antidiabetic, Aspirin, Atropine, Cardiac, Diuretics, Drug, NSAIDs Another extracted example is Triamcinolone → According, Chang, Perrigo, Prohibited List, S9, TA, Teva, World Anti-Doping Agency. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
effects side include use due risk action well blood concentrations also infections used muscle glucocorticoid osteoporosis inflammation plasma medical drugs
TTTA extracted 68 structured relationships around Triamcinolone. Examples in this analysis include Triamcinolone → 3D model (JSmol) → Interactive image and Triamcinolone → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Triamcinolone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Triamcinolone | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Triamcinolone | ATC code | A01AC01 (WHO) C05AA12 (WHO), D07AB09 (WHO), H02AB08 (WHO), R01AD11 (WHO), R03BA06 (WHO), S01BA05 (WHO) | 1.00 | infobox |
| Triamcinolone | Bioavailability | >90% | 1.00 | infobox |
| Triamcinolone | CAS Number | 124-94-7 Y | 1.00 | infobox |
| Triamcinolone | ChEBI | CHEBI:9667 N | 1.00 | infobox |
| Triamcinolone | ChEMBL | ChEMBL1451 Y | 1.00 | infobox |
| Triamcinolone | ChemSpider | 29046 Y | 1.00 | infobox |
| Triamcinolone | CompTox Dashboard (EPA) | DTXSID1040742 | 1.00 | infobox |
| Triamcinolone | DrugBank | DB00620 Y | 1.00 | infobox |
| Triamcinolone | ECHA InfoCard | 100.004.290 | 1.00 | infobox |
| Triamcinolone | Elimination half-life | 200–300 minutes (plasma), up to 36 hours (total) | 1.00 | infobox |
| Triamcinolone | Excretion | Urine (75%) and faeces (25%) | 1.00 | infobox |
| Triamcinolone | Formula | C21H27FO6 | 1.00 | infobox |
| Triamcinolone | IUPHAR/BPS | 2870 | 1.00 | infobox |
| Triamcinolone | KEGG | D00385 Y | 1.00 | infobox |
| Triamcinolone | Legal status | AU: S4 (Prescription only) / S3 | 1.00 | infobox |
| Triamcinolone | Legal status | UK: POM (Prescription only) / P | 1.00 | infobox |
| Triamcinolone | Legal status | US: ℞-only / OTC (Nasacort, intranasal) | 1.00 | infobox |
| Triamcinolone | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Triamcinolone | License data | US DailyMed: Triamcinolone | 1.00 | infobox |
| Triamcinolone | MedlinePlus | a601122 | 1.00 | infobox |
| Triamcinolone | Melting point | 260 to 271 °C (500 to 520 °F) | 1.00 | infobox |
| Triamcinolone | Metabolism | Liver | 1.00 | infobox |
| Triamcinolone | Molar mass | 394.439 g·mol−1 | 1.00 | infobox |
| Triamcinolone | Onset of action | (2–)24(–48) hours | 1.00 | infobox |
| Triamcinolone | Pregnancy category | AU: A | 1.00 | infobox |
| Triamcinolone | Protein binding | 68%[citation needed] | 1.00 | infobox |
| Triamcinolone | PubChem CID | 31307 | 1.00 | infobox |
| Triamcinolone | Routes of administration | By mouth, topical, intranasal, intramuscular, intra-articular, intra-synovial | 1.00 | infobox |
The concept neighborhoods around Triamcinolone bring nearby vocabulary together. In this analysis, examples include Topical, Treat and Effects. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Triamcinolone, one of the stronger structural bridges in this analysis connects Triamcinolone with Interactions. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Triamcinolone to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Community, Culture, Applications & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Triamcinolone · EN edition · Analysis: TopicsToTalkAbout